Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nizet, T. A. C.
Right arrow Articles by Folgering, H. Th. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nizet, T. A. C.
Right arrow Articles by Folgering, H. Th. M.
(Chest. 2005;127:1904-1910.)
© 2005 American College of Chest Physicians

Survival of Chronic Hypercapnic COPD Patients Is Predicted by Smoking Habits, Comorbidity, and Hypoxemia*

Tessa A. C. Nizet, MD; Frank J. J. van den Elshout, MD, PhD; Yvonne F. Heijdra, MD, PhD; Marjo J. T. van de Ven, MD, PhD; Paul G. H. Mulder, PhD and Hans Th. M. Folgering, MD, PhD

* From the Department of Pulmonary Diseases (Drs. Nizet, van den Elshout, and van de Ven), Rijnstate Hospital Arnhem, Arnhem; Department of Pulmonary Diseases (Dr. Heijdra), University Medical Center St. Radboud Nijmegen, Nijmegen; Department of Epidemiology & Biostatistics (Dr. Mulder), Erasmus University Medical Center Rotterdam, Rotterdam; and Department of Pulmonary Diseases Dekkerswald (Dr. Folgering), University of Nijmegen, Nijmegen, the Netherlands.

Correspondence to: Tessa A. C. Nizet, MD, Department of Pulmonary Diseases, Rijnstate Hospital Arnhem, PO Box 9555, 6800 TA Arnhem, the Netherlands; e-mail: tnizet{at}mmc.nl

Study objectives: Chronic hypercapnia in patients with COPD has been associated with a poor prognosis. We hypothesized that, within this group of chronic hypercapnic COPD patients, factors that could mediate this hypercapnia, such as decreased maximum inspiratory mouth pressure (PImax), decreased maximum expiratory mouth pressure (PEmax), and low hypercapnic ventilatory response (HCVR), could be related to survival. Other parameters, such as arterial blood gas values, airway obstruction (FEV1), body mass index (BMI), current smoking status, and the presence of comorbidity were studied as well.

Methods: A cohort of 47 chronic hypercapnic COPD patients recruited for short-term trials (1 to 3 weeks) in our institute was followed up for 3.8 years on average. Survival was analyzed using a Cox proportional hazards model. The risk factors considered were analyzed, optimally adjusted for age and gender.

Results: At the time of analysis 18 patients (10 male) were deceased. After adjusting for age and gender, PImax, PEmax, and HCVR were not correlated with survival within this hypercapnic group. Current smoking (hazard ratio [HR], 7.0; 95% confidence interval [CI], 1.4 to 35.3) and the presence of comorbidity (HR, 5.5; 95% CI, 1.7 to 18.7) were associated with increased mortality. A higher PaO2 affected survival positively (HR, 0.6 per 5 mm Hg; 95% CI, 0.4 to 1.0). PaCO2 tended to be lower in survivors, but this did not reach statistical significance (HR, 2.0 per 5 mm Hg; 95% CI, 0.9 to 4.3). FEV1 and BMI were not significantly related with survival in hypercapnic COPD patients.

Conclusion: In patients with chronic hypercapnia, only smoking status, the presence of comorbidity, and PaO2 level are significantly associated with survival. Airway obstruction, age, and BMI are known to be predictors of survival in COPD patients in general. However, these parameters do not seem to significantly affect survival once chronic hypercapnia has developed.

Key Words: control of breathing • pulmonary diseases, chronic obstructive • hypercapnia • respiratory muscle function • survival







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.